Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Other Non-Current Assets (2018 - 2025)

Historic Other Non-Current Assets for Neurogene (NGNE) over the last 6 years, with Q3 2025 value amounting to $1.1 million.

  • Neurogene's Other Non-Current Assets rose 3472.75% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 3472.75%. This contributed to the annual value of $975000.0 for FY2024, which is 2761.78% up from last year.
  • Neurogene's Other Non-Current Assets amounted to $1.1 million in Q3 2025, which was up 3472.75% from $1.1 million recorded in Q2 2025.
  • Neurogene's Other Non-Current Assets' 5-year high stood at $1.1 million during Q2 2025, with a 5-year trough of $524000.0 in Q3 2023.
  • Its 3-year average for Other Non-Current Assets is $825272.7, with a median of $794000.0 in 2024.
  • The largest annual percentage gain for Neurogene's Other Non-Current Assets in the last 5 years was 5057.25% (2024), contrasted with its biggest fall of 1790.06% (2024).
  • Over the past 3 years, Neurogene's Other Non-Current Assets (Quarter) stood at $764000.0 in 2023, then increased by 27.62% to $975000.0 in 2024, then increased by 9.03% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and $896000.0 during Q1 2025.